This inventor holds 11 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignee: Novartis Ag. Active years: 2013-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2026
Title: Zhengtian Yu: Innovator in Pharmaceutical Compounds
Introduction
Zhengtian Yu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds. With a total of nine patents to his name, Yu has established himself as a key figure in the industry.
Latest Patents
Among his latest patents are the Triazolopyrimidine compounds and their uses. These compounds, represented by a specific formula, have been shown to be effective in treating PRC2-mediated diseases or disorders. The detailed structure of these compounds includes various substituents, which are defined in the patent documentation.
Career Highlights
Zhengtian Yu currently works at Novartis AG, a leading global healthcare company. His work focuses on the research and development of pharmaceutical solutions that address critical health issues. His innovative approach has led to advancements in the treatment of complex diseases.
Collaborations
Yu collaborates with several talented individuals in his field, including Yuan Mi and Ho Man Chan. These partnerships enhance the research and development process, fostering an environment of creativity and innovation.
Conclusion
Zhengtian Yu's contributions to pharmaceutical innovations are noteworthy, and his work continues to impact the industry positively. His dedication to developing effective treatments showcases the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile